阿莫西西林是一种β-乳酸胺抗生素,增强了影响线粒体的癌细胞中西斯的敏感性
Yoshino Takami1, Kazuo Tomita2, Kento Igarashi2
1Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, 890-8544, Japan; Department of Oral and Maxillofacial Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, 890-8544, Japan.
Biochemical and biophysical research communications
|April 26, 2025
概括
阿莫西西林增强了西斯普拉丁的作用.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿莫西西林 (AMPC) 是一种广泛使用的抗生素.
- 癌细胞表现出改变的代谢途径和药物敏感性.
- 线粒体功能障碍在癌症进展和细胞死亡中起着至关重要的作用.
研究的目的:
- 调查阿莫西西林对西斯普拉丁抗癌功效的影响.
- 阐明阿莫西西林影响癌细胞活力的机制.
- 确定线粒体功能障碍和铁死在阿莫西西林增强的抗癌作用中的作用.
主要方法:
- 用阿莫西西林 (AMPC) 治疗宫癌 (HeLa) 和口腔状细胞癌 (SAS) 细胞.
- 评估线粒体功能,包括活性氧物种 (ROS) 水平,膜潜力和铁 (Fe2+) 水平.
- 在AMPC和西斯普拉丁联合治疗后,癌细胞和正常纤维细胞 (VA-13,HPLF) 中细胞活性的评估.
- 使用铁化剂phenanthroline对铁化作用的研究.
- 对癌细胞与正常细胞中的阿莫西西林载体 (PEPT1,PEPT2) 表达的分析.
主要成果:
- 氨基西林 (10μg/mL) 显著增加了线粒体ROS,降低了线粒体膜潜力,并降低了HeLa和SAS细胞中的线粒体Fe2+水平.
- 服用阿莫西西林和西斯普拉丁的联合治疗显著降低了HeLa和SAS细胞的活力,但并没有降低正常细胞的活力.
- 氨基没有增强dcetaxel的抗癌作用.
- 亚莫西西林增强西斯普拉丁的抗癌效应被芬安罗林阻断,证实了铁亡的参与.
- 与正常细胞相比,癌细胞中观察到氨基素载体PEPT1和PEPT2的更高表达.
结论:
- 氨基西林通过诱导线粒体功能障碍和铁亡,特别是在癌细胞中,增强了西斯的抗癌作用.
- 对癌细胞的选择性毒性归因于通过PEPT1/PEPT2载体通过更高的阿莫西林吸收.
- 这项研究表明,在特定的癌症治疗中,将阿莫西西林与西斯普拉丁结合起来,是一种潜在的新疗法策略.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
01:46Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
00:57Antibiotic Selection
51.9K
Overview
51.9K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K